- Home
- SAVA vs LGO Comparison
SAVA vs LGO Comparison
Compare SAVA & LGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- LGO
- Stock Information
- Founded
- SAVA 1998
- LGO 1988
- Country
- SAVA United States
- LGO Canada
- Employees
- SAVA N/A
- LGO N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- LGO
- Sector
- SAVA Health Care
- LGO
- Exchange
- SAVA Nasdaq
- LGO Nasdaq
- Market Cap
- SAVA 113.8M
- LGO 111.6M
- IPO Year
- SAVA N/A
- LGO 2007
- Fundamental
- Price
- SAVA $2.55
- LGO $1.76
- Analyst Decision
- SAVA Buy
- LGO Strong Buy
- Analyst Count
- SAVA 3
- LGO 1
- Target Price
- SAVA $111.50
- LGO $3.70
- AVG Volume (30 Days)
- SAVA 1.3M
- LGO 231.9K
- Earning Date
- SAVA 03-07-2025
- LGO 03-20-2025
- Dividend Yield
- SAVA N/A
- LGO N/A
- EPS Growth
- SAVA N/A
- LGO N/A
- EPS
- SAVA N/A
- LGO N/A
- Revenue
- SAVA N/A
- LGO $144,822,000.00
- Revenue This Year
- SAVA N/A
- LGO N/A
- Revenue Next Year
- SAVA N/A
- LGO $33.05
- P/E Ratio
- SAVA N/A
- LGO N/A
- Revenue Growth
- SAVA N/A
- LGO N/A
- 52 Week Low
- SAVA $2.23
- LGO $1.38
- 52 Week High
- SAVA $42.20
- LGO $2.84
- Technical
- Relative Strength Index (RSI)
- SAVA 41.47
- LGO 44.45
- Support Level
- SAVA $2.25
- LGO $1.72
- Resistance Level
- SAVA $2.36
- LGO $1.91
- Average True Range (ATR)
- SAVA 0.14
- LGO 0.17
- MACD
- SAVA 0.17
- LGO -0.02
- Stochastic Oscillator
- SAVA 50.85
- LGO 7.14
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The Company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The Company has six operating segments: sales & trading wich generates key revenue, mine properties, corporate, exploration and evaluation properties, Largo Clean Energy, and Largo Physical Vanadium.